Ro Review (2026): Worth It for Insurance Help?

Affiliate disclosure: This article contains affiliate links to a compounded-semaglutide provider, and allcheminfo.com may earn a commission if you use them. allcheminfo is not affiliated with Ro, and this review of Ro is independent of that relationship. This article is informational and is not medical advice.

Ro is one of the older and larger names in American telehealth — it launched in 2017 as Roman, a men’s health service, and has since grown into a broad direct-to-consumer platform that now includes a weight-loss program, the Ro Body Program. If you are weighing Ro for a GLP-1, it sits in a different place from some of its competitors: Ro never built its identity on cheap compounded semaglutide, it sells mostly brand-name, FDA-approved medication, and it was the first telehealth platform to integrate with Eli Lilly’s LillyDirect. This review covers what Ro offers for weight loss, what it actually costs — including a layered pricing structure that is the single most common source of complaints — the insurance concierge that is genuinely Ro’s strongest feature, the company’s reputation, and who Ro is and is not a good fit for.

What Ro Is and How the Body Program Works

Ro is a direct-to-consumer telehealth company. Its weight-loss offering, the Ro Body Program, connects you with licensed providers who can prescribe GLP-1 medication and then manage your treatment over time.

What Ro prescribes is, for the most part, brand-name medication. Its current GLP-1 lineup includes Wegovy — both the pen and the newer oral pill — Ozempic, Zepbound in both KwikPen and vial form, and Foundayo, the orforglipron pill approved in 2026. These are all FDA-approved drugs. Ro also offers compounded semaglutide, but only in a limited number of states, and — unlike its brand-name drugs — compounded semaglutide is not FDA-approved, a distinction worth understanding if you are offered it. Compounded medication is a small and shrinking part of what Ro does, not its core. That matters, because it places Ro on the more conventional side of the telehealth GLP-1 market — the part built on FDA-approved drugs rather than on the compounded products that have drawn an FDA enforcement crackdown.

One detail underlines that positioning: Ro was the first telehealth platform to integrate with LillyDirect, Eli Lilly’s own direct-to-consumer pharmacy, to offer Zepbound. Being chosen as Lilly’s first integration partner is a meaningful signal of established standing.

Mechanically, the Body Program works on a membership. You complete an online intake, a licensed provider reviews your medical history, and if appropriate you are prescribed a GLP-1 and enrolled in the membership — which includes ongoing provider check-ins, dose management, side-effect support, messaging access, a structured health-coaching curriculum, and the insurance concierge service covered below. How that membership is priced, though, is where Ro generates the most friction.

Pricing — the Membership-Plus-Medication Structure

Ro’s pricing has two separate parts, and the relationship between them is the single most important thing to understand before signing up — and the single most common source of complaints.

The first part is the Body membership. Ro has recently priced this at a discounted rate for the first month — quoted variously between roughly $39 and $99 depending on the offer — then around $145 to $149 a month after that. This membership is cash-pay only: insurance does not cover it, and it continues for as long as you use a GLP-1 through Ro.

The second part is the medication, billed separately. For brand-name drugs, Ro essentially passes through the manufacturers’ self-pay prices: Wegovy has been offered with an introductory rate around $199 a month before rising to roughly $349 for higher doses; Zepbound vials run about $299 to $449 a month depending on dose. So the all-in cost of brand-name treatment through Ro — membership plus medication — typically lands somewhere around $450 to $500 a month at standard pricing, before any insurance is applied. Because promotional offers shift, treat those figures as a guide and confirm the current numbers on Ro’s site.

Here is the friction point. Across Ro’s customer reviews, the most consistent complaint is not about the medication or the providers — it is about this two-part structure. Many reviewers describe what feels to them like a bait-and-switch: they are shown an attractive introductory price on the medication, enroll, and only then fully register the separate membership fee of roughly $145 a month stacked on top, continuing indefinitely. Ro does publish its membership pricing, but its marketing leads with the medication’s introductory price, and a large number of customers still come away feeling the full cost was not obvious upfront. There are also recurring complaints about cancellation — for example, cancelling the subscription unexpectedly cancelling a medication order — and about partial refunds. The lesson for a prospective customer is concrete: before enrolling, find the exact membership fee, confirm it is separate from and on top of the medication price, calculate your true all-in monthly cost, and read the cancellation terms.

The Insurance Concierge — Ro’s Real Differentiator (and Its Limit)

If Ro has one feature that genuinely sets it apart, it is the insurance concierge.

Most cash-pay telehealth platforms simply sell you the medication and leave insurance entirely to you. Ro does something more active: its insurance concierge reviews your plan to determine whether your GLP-1 is covered, and if a prior authorization is required, Ro’s team prepares and submits the paperwork on your behalf. If coverage is approved, your medication cost can drop to your plan’s copay — potentially as little as $0 to $25 a month when a manufacturer savings card is also applied. If it is denied, Ro works with your provider on alternatives. For a patient who finds insurance paperwork bewildering — and prior authorization for GLP-1s is genuinely bewildering — this is real, substantive help, and it is the clearest argument in Ro’s favor. One practical trade-off comes with it: the insurance route takes longer, since prior authorization can mean a two-to-three-week wait before medication arrives, against roughly a week if you simply pay cash.

But the concierge has a hard limit, and it is an important one. It works with commercial insurance only. Ro cannot coordinate GLP-1 coverage for Medicaid, for most Medicare plans, or for other government programs. If your coverage is through a government plan, the concierge — Ro’s standout feature — does nothing for you, and you are left paying the membership plus the cash medication price. For a large share of patients, that single limitation removes the main reason to choose Ro at all.

Reputation — Trustpilot, the BBB, and the Pricing-Confusion Pattern

Ro’s customer reputation is mixed, and lands roughly in the middle of the telehealth field.

On Trustpilot, Ro scores around 3.8 out of 5 across more than three thousand reviews — mediocre, though somewhat better than several competitors. At the Better Business Bureau, Ro is accredited and carries a B rating, with several hundred complaints on file and a low average score from the smaller pool of BBB customer reviews. A B rating is middling — better than the worst operators in this space, short of the best.

More useful than the scores is the pattern within the complaints. As the pricing section described, the dominant theme is not medication quality or provider competence — by most accounts Ro’s clinical side functions — but pricing and billing: the membership fee customers feel was not made clear, confusion over what was charged and when, and difficulties around cancellation and refunds. That consistency is informative. It tells you the main risk with Ro is not your treatment; it is the commercial experience around it. If you go in with the pricing structure fully understood and your cancellation rights noted, you remove most of what Ro’s unhappy customers are unhappy about.

The honest summary: Ro is a legitimate, established platform with a functioning clinical service and a genuinely useful insurance feature, paired with a pricing structure that a substantial minority of customers find confusing or worse. Both halves are real.

Frequently Asked Questions

Is Ro legitimate?

Yes. Ro has operated since 2017, was the first telehealth platform to integrate with Eli Lilly’s LillyDirect, uses licensed providers, and sells mostly brand-name, FDA-approved GLP-1 medication. Its reputation is mid-range — a Trustpilot score around 3.8 and a BBB B rating with accreditation — and it draws consistent complaints about pricing clarity, but it is a real, conventional telehealth platform, not a fly-by-night operation.

How much does Ro cost for a GLP-1?

There are two separate charges: the Body membership, recently around $39 to $99 for the first month and roughly $145 to $149 a month after, plus the medication billed separately — brand Wegovy from about $199 introductory to $349, Zepbound vials about $299 to $449. All in, expect somewhere around $450 to $500 a month at standard pricing before insurance. Confirm current figures on Ro’s site.

Does Ro take insurance?

The Body membership itself is cash-pay — insurance does not cover it. But for the medication, Ro’s insurance concierge will work with your commercial insurer, submit prior-authorization paperwork, and can bring the drug cost down to a copay if coverage is approved. Crucially, the concierge does not work with Medicaid, most Medicare plans, or other government programs.

Does Ro sell compounded semaglutide?

Mostly no. Ro sells brand-name, FDA-approved GLP-1 medication as its core offering. It does offer compounded semaglutide, but only in a limited number of states, and it is a small and shrinking part of what the platform does.

Is Ro or Hims better for GLP-1?

They are more alike than different: both are membership-plus-medication platforms now selling brand-name GLP-1s. Ro’s clearest edge is its insurance concierge, which actively works commercial coverage for you — useful if you are commercially insured. Otherwise the structures are similar, and neither is the lowest-cost route. Our Hims review covers that platform in detail; compare current pricing for both before deciding.

The Verdict — Who Ro Is For

Ro is a legitimate, established telehealth platform — one of the more conventional players in the GLP-1 space. It sells brand-name, FDA-approved medication, it was Eli Lilly’s first LillyDirect integration partner, and its insurance concierge is a genuinely useful feature most competitors do not match. It is also a membership-plus-medication service whose layered pricing is a consistent source of customer frustration, and whose best feature does not work for everyone.

Ro is a reasonable fit if you have commercial health insurance and want one platform to handle GLP-1 eligibility, prior-authorization paperwork, the prescription and ongoing follow-up — the insurance concierge is built for exactly this person; you want brand-name, FDA-approved medication with structured coaching and provider support; and you have calculated, and accepted, the all-in cost of membership plus medication.

Ro is a poor fit if you are on Medicaid, Medicare or another government plan, because Ro’s concierge — its main advantage — cannot help you there; if your priority is the lowest possible monthly cost, since compounded semaglutide from a dedicated cash-pay provider, or buying brand medication directly, will usually cost less than Ro’s membership-plus-medication total; or if you are not prepared to track a two-part subscription, because the layered billing is what Ro’s unhappy customers most often regret.

The bottom line: for a commercially insured patient who values having coverage fought for and paperwork handled, Ro is one of the stronger telehealth options, and the membership can be worth its cost. For almost everyone else — government-insured patients, and anyone whose main goal is the lowest price — the math is harder to justify, and other routes deserve a look. For lower-cost compounded semaglutide specifically, see our Direct Meds review; for the full range of payment options across every GLP-1, our GLP-1 cost guide.

This article is general information, not medical advice. Pricing, programs and a company’s reputation record reflect the situation as of May 2026 and can change; confirm current details directly before making decisions.